203 related articles for article (PubMed ID: 33185535)
1. Successful treatment of adalimumab-induced paradoxical psoriatic arthritis with risankizumab.
Watabe D; Amano H
Eur J Dermatol; 2020 Oct; 30(5):611-612. PubMed ID: 33185535
[No Abstract] [Full Text] [Related]
2. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
[TBL] [Abstract][Full Text] [Related]
3. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
[TBL] [Abstract][Full Text] [Related]
4. Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.
Gniadecki R; Bang B; Sand C
Br J Dermatol; 2016 May; 174(5):1145-6. PubMed ID: 26522308
[No Abstract] [Full Text] [Related]
5. Flare of palmoplantar psoriasis with ustekinumab.
Daniel BS; Baker C; Foley P
Australas J Dermatol; 2020 Feb; 61(1):63-65. PubMed ID: 31372980
[No Abstract] [Full Text] [Related]
6. Tumor necrosis factor (TNF) inhibitors revolutionalized therapy for both psoriasis and psoriatic arthritis. Foreword.
Gottlieb AB
Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S3-4. PubMed ID: 24777570
[No Abstract] [Full Text] [Related]
7. A case of tumour necrosis factor-α inhibitor- and rituximab-induced plantar pustular psoriasis that completely resolved with tocilizumab.
Jayasekera P; Parslew R; Al-Sharqi A
Br J Dermatol; 2014 Dec; 171(6):1546-9. PubMed ID: 24890762
[TBL] [Abstract][Full Text] [Related]
8. Response of severe psoriasis to infliximab.
Mang R; Stege H; Ruzicka T; Krutmann J
Dermatology; 2002; 204(2):156-7. PubMed ID: 11937748
[No Abstract] [Full Text] [Related]
9. Successful treatment of palmoplantar pustular psoriasis with brodalumab.
Nakao M; Asano Y; Kamata M; Yoshizaki A; Sato S
Eur J Dermatol; 2018 Aug; 28(4):538-539. PubMed ID: 30129522
[No Abstract] [Full Text] [Related]
10. A host of novel agents for treating psoriasis, psoriatic arthritis stir interest.
Lamberg L
JAMA; 2003 Jun; 289(21):2779-80, 2783. PubMed ID: 12783895
[No Abstract] [Full Text] [Related]
11. Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review.
Barešić M; Reihl Crnogaj M; Zadro I; Anić B
Rheumatol Int; 2021 Dec; 41(12):2233-2239. PubMed ID: 34557936
[TBL] [Abstract][Full Text] [Related]
12. Arthritis possibly induced and exacerbated by a tumour necrosis factor antagonist in a patient with psoriasis vulgaris.
Takahashi T; Asano Y; Shibata S; Nakamura K; Nakao M; Shida R; Mitsui A; Araki M; Watanabe R; Fujita H; Tada Y; Sato S
Br J Dermatol; 2015; 172(5):1458-60. PubMed ID: 25565011
[No Abstract] [Full Text] [Related]
13. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab.
Bartke U; Venten I; Kreuter A; Gubbay S; Altmeyer P; Brockmeyer NH
Br J Dermatol; 2004 Apr; 150(4):784-6. PubMed ID: 15099388
[No Abstract] [Full Text] [Related]
14. Treatment of psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab for the treatment of severe psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A; Chimenti MS; Chimenti S
Expert Opin Biol Ther; 2008 Mar; 8(3):363-70. PubMed ID: 18294106
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with the prescription of "traditional" or "biological" systemic treatment in psoriasis.
Tabolli S; Paradisi A; Giannantoni P; Gubinelli E; Abeni D
J Dermatolog Treat; 2015 Feb; 26(1):37-40. PubMed ID: 24559128
[TBL] [Abstract][Full Text] [Related]
17. A Case Series of TNF Inhibitor-Induced Psoriasis Successfully Treated With Upadacitinib.
Woodbury MJ; Grant C; Perez-Chada L; LaChance AH; Merola JF
J Drugs Dermatol; 2024 Feb; 23(2):e60-e63. PubMed ID: 38306123
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
[TBL] [Abstract][Full Text] [Related]
19. [Novel biologics in treatment of psoriatic arthritis].
ZHOU J; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):404-8. PubMed ID: 19693980
[TBL] [Abstract][Full Text] [Related]
20. Acneiform eruption as a probable paradoxical reaction to adalimumab.
Fernández-Crehuet P; Ruiz-Villaverde R
Int J Dermatol; 2015 Aug; 54(8):e306-8. PubMed ID: 24697221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
